220:
235:
132:
On April 19, 2011, the company initiated Phase III studies of dalbavancin for intravenous (IV) treatment of acute bacterial skin and skin structure infections.
158:
225:
176:
230:
177:"Durata Therapeutics Initiates Phase 3 Study of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections"
195:
98:
28:
86:
122:
117:
On
December 21, 2009, the company acquired Vicuron Pharmaceuticals and its drug candidate,
200:
214:
180:
162:
118:
102:
106:
75:
159:"Newly Formed Durata Therapeutics Acquires Pfizer's Vicuron Subsidiary"
136:
135:
In 2012, the company moved its global headquarters from
Morristown to
126:
105:. On November 17, 2014, the company was acquired by Actavis (now
82:
70:
52:
34:
24:
97:was a clinical development stage company in the
221:Pharmaceutical companies disestablished in 2014
196:"Durata biotech moving headquarters to Chicago"
8:
19:
18:
236:American companies disestablished in 2014
139:and received $ 2 million in tax credits.
150:
7:
194:Frost, Peter (November 14, 2012).
101:which focused on the treatment of
14:
226:2009 establishments in New Jersey
121:, a long-acting semisynthetic
1:
231:2014 mergers and acquisitions
40:; 15 years ago
252:
129:and commenced operations.
74:Acquired by Actavis (now
20:Durata Therapeutics, Inc.
99:pharmaceutical industry
29:Pharmaceutical industry
87:Morristown, New Jersey
16:Pharmaceutical company
109:) for $ 675 million.
58:; 9 years ago
165:. December 21, 2009.
95:Durata Therapeutics
21:
183:. April 19, 2011.
179:(Press release).
161:(Press release).
125:antibiotic, from
92:
91:
63:November 17, 2014
56:November 17, 2014
243:
206:
205:
191:
185:
184:
173:
167:
166:
155:
123:lipoglycopeptide
66:
64:
59:
48:
46:
41:
22:
251:
250:
246:
245:
244:
242:
241:
240:
211:
210:
209:
201:Chicago Tribune
193:
192:
188:
175:
174:
170:
157:
156:
152:
148:
142:
115:
62:
60:
57:
44:
42:
39:
17:
12:
11:
5:
249:
247:
239:
238:
233:
228:
223:
213:
212:
208:
207:
186:
168:
149:
147:
144:
114:
111:
90:
89:
84:
80:
79:
72:
68:
67:
54:
50:
49:
36:
32:
31:
26:
15:
13:
10:
9:
6:
4:
3:
2:
248:
237:
234:
232:
229:
227:
224:
222:
219:
218:
216:
203:
202:
197:
190:
187:
182:
181:Business Wire
178:
172:
169:
164:
160:
154:
151:
145:
143:
140:
138:
133:
130:
128:
124:
120:
112:
110:
108:
104:
100:
96:
88:
85:
81:
77:
73:
69:
55:
51:
37:
33:
30:
27:
23:
199:
189:
171:
153:
141:
134:
131:
116:
94:
93:
83:Headquarters
163:PR Newswire
119:dalbavancin
215:Categories
146:References
103:infections
107:Allergan
76:Allergan
25:Industry
137:Chicago
113:History
61: (
53:Defunct
43: (
35:Founded
127:Pfizer
71:Fate
45:2009
38:2009
217::
198:.
204:.
78:)
65:)
47:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.